Current Molecular Medicine is an interdisciplinary journal focused on providing the readership with current and comprehensive reviews, original research articles, short communications/letters and drug clinical trial studies on fundamental molecular mechanisms of disease pathogenesis, the development of molecular-diagnosis and/or novel approaches to rational treatment. The reviews should be of significant interest to basic researchers and clinical investigators in molecular medicine. Periodically the journal invites guest editors to devote an issue on a basic research area that shows promise to advance our understanding of the molecular mechanism(s) of a disease or has potential for clinical applications.


Articles from the journal Current Molecular Medicine, Volume 16 Issue 1:


  • Editorial: Look for Changes in 2016
  • Development of New Therapeutic Agents for Fibrodysplasia Ossificans Progressiva
  • Calreticulin in the Heart: From Embryological Development to Cardiac Pathology
  • Modulation of intracellular pH in human ovarian cancer
  • Vagus nerve stimulation in treating depression: A tale of two stories
  • Fibroblast Growth Factor Receptors: From the Oncogenic Pathway to Targeted Therapy
  • Jade-1: its structure, regulation and functions in the renal cancer
  • The Plasma microRNA miR-1914* and -1915 Suppresses Chemoresistant in Colorectal Cancer Patients by Down-regulating NFIX
  • Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) Function by Inhibiting ERK Signaling in Pancreatic Ductal Adenocarcinoma
  • DREADD in Parvalbumin Interneurons of the Dentate Gyrus Modulates Anxiety, Social Interaction and Memory Extinction

For details on the articles, please visit this link ::